The most salient feature was the neuronal nuclear decrease of NSun2 immunoreactivity in both brain regions of AD patients compared to controls, as confirmed by quantification of immunostained slides (Fig. 1a–c). This evidence concerns the gene NSUN2 and Alzheimer disease.